← Back to News

Various

Analyst Upgrades and Downgrades For the Week of May 28th

Analyst upgrades, downgrades, and more

By Justin Nugent · May 29, 2024
Analyst Upgrades and Downgrades For the Week of May 28th

Friday, May 31st, 2024

Upgrades:

  • Asana (ASAN)
    • Brokerage Firm: Piper Sandler
    • Ratings Change: Underweight >> Neutral
    • Price Target: $18 >> $16
  • Bilibili (BILI)
    • Brokerage Firm: UBS
    • Ratings Change: Neutral >> Buy
    • Price Target: $11.9 >> $18
  • Century Communities (CCS)
    • Brokerage Firm: Wedbush
    • Ratings Change: Underperform >> Neutral
    • Price Target: $82
  • Fifth Third (FITB)
    • Brokerage Firm: Wolfe Research
    • Ratings Change: Peer Perform >> Outperform
    • Price Target: $43
  • Hormel Foods (HRL)
    • Brokerage Firm: JP Morgan
    • Ratings Change: Underweight >> Neutral
    • Price Target: $28 >> $29
  • Independent Bank Group (IBTX)
    • Brokerage Firm: Piper Sandler
    • Ratings Change: Underweight >> Overweight
    • Price Target: $38 >> $58
  • NetApp (NTAP)
    • Brokerage Firm: JP Morgan
    • Ratings Change: Underweight >> Neutral
    • Price Target: $95 >> $125
  • Wynn Resorts (WYNN)
    • Brokerage Firm: Seaport Research Partners
    • Ratings Change: Neutral >> Buy
    • Price Target: $116
  • Heartland Financial (HTLF)
    • Brokerage Firm: Keefe Bruyette
    • Ratings Change: Mkt Perform >> Outperform
    • Price Target: $54
  • Hancock Whitney (HWC)
    • Brokerage Firm: Keefe Bruyette
    • Ratings Change: Mkt Perform >> Outperform
    • Price Target: $55
  • Seacoast Banking (SBCF)
    • Brokerage Firm: Keefe Bruyette
    • Ratings Change: Mkt Perform >> Outperform
    • Price Target: $27
  • UMB Financial Corporation (UMBF)
    • Brokerage Firm: Keefe Bruyette
    • Ratings Change: Mkt Perform >> Outperform
    • Price Target: $98

Downgrades:

  • ConnectOne Bancorp (CNOB)
    • Brokerage Firm: Keefe Bruyette
    • Ratings Change: Outperform >> Mkt Perform
  • OceanFirst Finl (OCFC)
    • Brokerage Firm: Keefe Bruyette
    • Ratings Change: Outperform >> Mkt Perform
    • Price Target: $18
  • Valley National (VLY)
    • Brokerage Firm: Keefe Bruyette
    • Ratings Change: Outperform >> Mkt Perform
    • Price Target: $8
  • Cactus (WHD)
    • Brokerage Firm: Johnson Rice
    • Ratings Change: Buy >> Accumulate
  • Maxeon Solar (MAXN)
    • Brokerage Firm: Northland Capital
    • Ratings Change: Market Perform >> Under Perform
    • Price Target: $7 >> $0.5

Coverage Initiated:

  • Abacus Life (ABL)
    • Brokerage Firm: B. Riley Securities
    • Ratings Change: Buy
    • Price Target: $16
  • AC Immune (ACIU)
    • Brokerage Firm: BTIG Research
    • Ratings Change: Buy
    • Price Target: $8
  • Arcellx (ACLX)
    • Brokerage Firm: Piper Sandler
    • Ratings Change: Overweight
    • Price Target: $70
  • Agree Realty (ADC)
    • Brokerage Firm: UBS
    • Ratings Change: Neutral
    • Price Target: $60
  • Allogene (ALLO)
    • Brokerage Firm: Piper Sandler
    • Ratings Change: Overweight
    • Price Target: $11
  • Apellis Pharmaceuticals (APLS)
    • Brokerage Firm: Piper Sandler
    • Ratings Change: Neutral
    • Price Target: $46
  • Ascendis Pharma (ASND)
    • Brokerage Firm: Stifel
    • Ratings Change: Buy
    • Price Target: $200
  • Beazer Homes (BZH)
    • Brokerage Firm: Oppenheimer
    • Ratings Change: Outperform
    • Price Target: $37
  • Elevation Oncology (ELEV)
    • Brokerage Firm: Piper Sandler
    • Ratings Change: Overweight
    • Price Target: $10
  • Essential Properties Realty Trust (EPRT)
    • Brokerage Firm: UBS
    • Ratings Change: Buy
    • Price Target: $30
  • Federal Signal (FSS)
    • Brokerage Firm: William Blair
    • Ratings Change: Outperform
  • Immunome (IMNM)
    • Brokerage Firm: Piper Sandler
    • Ratings Change: Overweight
    • Price Target: $27
  • Lionsgate Studios (LION)
    • Brokerage Firm: Citigroup
    • Ratings Change: Buy
    • Price Target: $14
  • Landsea Homes (LSEA)
    • Brokerage Firm: Oppenheimer
    • Ratings Change: Outperform
    • Price Target: $14
  • NNN REIT (NNN)
    • Brokerage Firm: UBS
    • Ratings Change: Neutral
    • Price Target: $41
  • PayPal (PYPL)
    • Brokerage Firm: New Street
    • Ratings Change: Buy
    • Price Target: $80
  • Quad/Graphics (QUAD)
    • Brokerage Firm: Rosenblatt
    • Ratings Change: Buy
    • Price Target: $7.5
  • Rubrik (RBRK)
    • Brokerage Firm: Cantor Fitzgerald
    • Ratings Change: Overweight
    • Price Target: $50
  • Sarepta Therapeutics (SRPT)
    • Brokerage Firm: Piper Sandler
    • Ratings Change: Overweight
    • Price Target: $157
  • W.P. Carey (WPC)
    • Brokerage Firm: UBS
    • Ratings Change: Neutral
    • Price Target: $57
  • Vestis (VSTS)
    • Brokerage Firm: William Blair
    • Ratings Change: Mkt Perform

Thursday, May 30th, 2024

Upgrades:

  • C3.ai (AI)
    • Brokerage Firm: Northland Capital
    • Ratings Change: Market Perform>>Outperform
    • Price Target: $35
  • Alignment Healthcare (ALHC)
    • Brokerage Firm: BofA Securities
    • Ratings Change: Neutral>>Buy
    • Price Target: $7.75>>$11
  • Datadog (DDOG)
    • Brokerage Firm: BofA Securities
    • Ratings Change: Neutral>>Buy
    • Price Target: $143>>$155
  • Corning (GLW)
    • Brokerage Firm: JP Morgan
    • Ratings Change: Neutral>>Overweight
    • Price Target: $37>>$43
  • Intl Game Tech. PLC (IGT)
    • Brokerage Firm: Stifel
    • Ratings Change: Hold>>Buy
    • Price Target: $24>>$26
  • Okta (OKTA)
    • Brokerage Firm: Evercore ISI
    • Ratings Change: In-line>>Outperform
    • Price Target: $102>>$122
  • PayPal (PYPL)
    • Brokerage Firm: Mizuho
    • Ratings Change: Neutral>>Buy
    • Price Target: $68>>$90
  • Radius Recycling (RDUS)
    • Brokerage Firm: Seaport Research Partners
    • Ratings Change: Sell>>Neutral
  • USA Compression Partners (USAC)
    • Brokerage Firm: Mizuho
    • Ratings Change: Underperform>>Neutral
    • Price Target: $23>>$26
  • US Cellular (USM)
    • Brokerage Firm: Wells Fargo
    • Ratings Change: Equal Weight>>Overweight
    • Price Target: $38>>$75
  • Ameren (AEE)
    • Brokerage Firm: Barclays
    • Ratings Change: Equal Weight>>Overweight
    • Price Target: $73>>$77
  • Ero Copper (ERO)
    • Brokerage Firm: Scotiabank
    • Ratings Change: Sector Perform>>Sector Outperform
  • Formula One Group (FWONA)
    • Brokerage Firm: Deutsche Bank
    • Ratings Change: Hold>>Buy
    • Price Target: $73>>$83
  • Hallador Energy (HNRG)
    • Brokerage Firm: B. Riley Securities
    • Ratings Change: Neutral>>Buy
    • Price Target: $8>>$9
  • Lifeway Foods (LWAY)
    • Brokerage Firm: Noble Capital Markets
    • Ratings Change: Market Perform>>Outperform
    • Price Target: $20

Downgrades:

  • Atlantica Sustainable Infrastructure plc (AY)
    • Brokerage Firm: UBS
    • Ratings Change: Buy>>Neutral
    • Price Target: $25>>$22
  • Ciena (CIEN)
    • Brokerage Firm: Rosenblatt
    • Ratings Change: Buy>>Neutral
    • Price Target: $65>>$52.5
  • Ecopetrol (EC)
    • Brokerage Firm: BofA Securities
    • Ratings Change: Neutral>>Underperform
  • FactSet (FDS)
    • Brokerage Firm: BofA Securities
    • Ratings Change: Neutral>>Underperform
    • Price Target: $500>>$407
  • First Solar (FSLR)
    • Brokerage Firm: Mizuho
    • Ratings Change: Buy>>Neutral
    • Price Target: $209>>$274
  • Generac (GNRC)
    • Brokerage Firm: Guggenheim
    • Ratings Change: Neutral>>Sell
    • Price Target: $120
  • Nutanix (NTNX)
    • Brokerage Firm: Northland Capital
    • Ratings Change: Outperform>>Market Perform
    • Price Target: $71
  • Oscar Health (OSCR)
    • Brokerage Firm: BofA Securities
    • Ratings Change: Buy>>Neutral
    • Price Target: $25>>$21
  • UiPath (PATH)
    • Brokerage Firm: BofA Securities
    • Ratings Change: Buy>>Neutral
    • Price Target: $30>>$16
  • UiPath (PATH)
    • Brokerage Firm: Truist
    • Ratings Change: Buy>>Hold
    • Price Target: $32>>$14
  • UiPath (PATH)
    • Brokerage Firm: William Blair
    • Ratings Change: Outperform>>Mkt Perform
  • UiPath (PATH)
    • Brokerage Firm: TD Cowen
    • Ratings Change: Buy>>Hold
    • Price Target: $28>>$17
  • UiPath (PATH)
    • Brokerage Firm: KeyBanc Capital Markets
    • Ratings Change: Overweight>>Sector Weight
  • CAVA Group (CAVA)
    • Brokerage Firm: Piper Sandler
    • Ratings Change: Overweight>>Neutral
    • Price Target: $63>>$92
  • Advanced Health Intelligence (AHI)
    • Brokerage Firm: Maxim Group
    • Ratings Change: Buy>>Hold
  • UiPath (PATH)
    • Brokerage Firm: Needham
    • Ratings Change: Buy>>Hold
  • Noah Holdings (NOAH)
    • Brokerage Firm: JP Morgan
    • Ratings Change: Overweight>>Neutral
    • Price Target: $18>>$13
  • Pure Storage (PSTG)
    • Brokerage Firm: Northland Capital
    • Ratings Change: Outperform>>Market Perform
    • Price Target: $58>>$68

Coverage Initiated:

  • Abeona Therapeutics (ABEO)
    • Brokerage Firm: Stifel
    • Ratings Change: Buy
    • Price Target: $21
  • Abbott Labs (ABT)
    • Brokerage Firm: Goldman
    • Ratings Change: Buy
    • Price Target: $121
  • Adaptimmune Therapeutics (ADAP)
    • Brokerage Firm: Scotiabank
    • Ratings Change: Sector Outperform
    • Price Target: $3.15
  • ADC Therapeutics (ADCT)
    • Brokerage Firm: Cantor Fitzgerald
    • Ratings Change: Overweight
  • Agilon Health (AGL)
    • Brokerage Firm: Robert W. Baird
    • Ratings Change: Neutral
    • Price Target: $6
  • Alignment Healthcare (ALHC)
    • Brokerage Firm: Robert W. Baird
    • Ratings Change: Outperform
    • Price Target: $10
  • Astrana Health (ASTH)
    • Brokerage Firm: Robert W. Baird
    • Ratings Change: Outperform
    • Price Target: $54
  • AstraZeneca (AZN)
    • Brokerage Firm: Goldman
    • Ratings Change: Buy
    • Price Target: $97
  • Baxter (BAX)
    • Brokerage Firm: Goldman
    • Ratings Change: Neutral
    • Price Target: $36
  • Bayer AG (BAYRY)
    • Brokerage Firm: Goldman
    • Ratings Change: Neutral
  • Becton Dickinson (BDX)
    • Brokerage Firm: Goldman
    • Ratings Change: Buy
    • Price Target: $274
  • Boston Scientific (BSX)
    • Brokerage Firm: Goldman
    • Ratings Change: Buy
    • Price Target: $90
  • Codexis (CDXS)
    • Brokerage Firm: Cantor Fitzgerald
    • Ratings Change: Overweight
    • Price Target: $11
  • The Cigna Group (CI)
    • Brokerage Firm: Robert W. Baird
    • Ratings Change: Outperform
    • Price Target: $388
  • Centene (CNC)
    • Brokerage Firm: Robert W. Baird
    • Ratings Change: Neutral
    • Price Target: $83
  • Chesapeake Utilities (CPK)
    • Brokerage Firm: Barclays
    • Ratings Change: Equal Weight
    • Price Target: $111
  • CVS Health (CVS)
    • Brokerage Firm: Robert W. Baird
    • Ratings Change: Neutral
    • Price Target: $61
  • Dexcom (DXCM)
    • Brokerage Firm: Redburn Atlantic
    • Ratings Change: Neutral
    • Price Target: $130
  • Elevance Health (ELV)
    • Brokerage Firm: Robert W. Baird
    • Ratings Change: Outperform
    • Price Target: $649
  • Edwards Lifesciences (EW)
    • Brokerage Firm: Goldman
    • Ratings Change: Buy
    • Price Target: $107
  • Amicus Therapeutics (FOLD)
    • Brokerage Firm: Wells Fargo
    • Ratings Change: Overweight
    • Price Target: $18
  • GE HealthCare (GEHC)
    • Brokerage Firm: Goldman
    • Ratings Change: Neutral
    • Price Target: $87
  • GlaxoSmithKline (GSK)
    • Brokerage Firm: Goldman
    • Ratings Change: Neutral
    • Price Target: $47
  • HCA (HCA)
    • Brokerage Firm: Robert W. Baird
    • Ratings Change: Outperform
    • Price Target: $396
  • Inozyme Pharma (INZY)
    • Brokerage Firm: Wells Fargo
    • Ratings Change: Overweight
    • Price Target: $14
  • Intuitive Surgical (ISRG)
    • Brokerage Firm: Goldman
    • Ratings Change: Buy
    • Price Target: $500
  • Janux Therapeutics (JANX)
    • Brokerage Firm: Scotiabank
    • Ratings Change: Sector Perform
    • Price Target: $47
  • Medtronic (MDT)
    • Brokerage Firm: Goldman
    • Ratings Change: Sell
    • Price Target: $83
  • Molina Healthcare (MOH)
    • Brokerage Firm: Robert W. Baird
    • Ratings Change: Outperform
    • Price Target: $405
  • Novo Nordisk A/S (NVO)
    • Brokerage Firm: Goldman
    • Ratings Change: Buy
    • Price Target: $156
  • Novartis AG (NVS)
    • Brokerage Firm: Goldman
    • Ratings Change: Buy
    • Price Target: $120
  • Oscar Health (OSCR)
    • Brokerage Firm: Robert W. Baird
    • Ratings Change: Outperform
    • Price Target: $28
  • Insulet (PODD)
    • Brokerage Firm: Redburn Atlantic
    • Ratings Change: Buy
    • Price Target: $235
  • Privia Health (PRVA)
    • Brokerage Firm: Robert W. Baird
    • Ratings Change: Outperform
    • Price Target: $23
  • Roche Hldg (RHHBY)
    • Brokerage Firm: Goldman
    • Ratings Change: Sell
  • Solventum Corporation (SOLV)
    • Brokerage Firm: Goldman
    • Ratings Change: Sell
    • Price Target: $54
  • Stryker (SYK)
    • Brokerage Firm: Goldman
    • Ratings Change: Neutral
    • Price Target: $372
  • Tenet Healthcare (THC)
    • Brokerage Firm: Robert W. Baird
    • Ratings Change: Outperform
    • Price Target: $153
  • TriSalus Life Sciences (TLSI)
    • Brokerage Firm: Canaccord Genuity
    • Ratings Change: Buy
    • Price Target: $12
  • Tandem Diabetes Care (TNDM)
    • Brokerage Firm: Redburn Atlantic
    • Ratings Change: Buy
    • Price Target: $60
  • Universal Health (UHS)
    • Brokerage Firm: Robert W. Baird
    • Ratings Change: Neutral
    • Price Target: $198
  • UnitedHealth (UNH)
    • Brokerage Firm: Robert W. Baird
    • Ratings Change: Outperform
    • Price Target: $597
  • Zimmer Biomet (ZBH)
    • Brokerage Firm: Goldman
    • Ratings Change: Neutral
    • Price Target: $129
  • Wag! Group (PET)
    • Brokerage Firm: Lake Street
    • Ratings Change: Buy
    • Price Target: $4
  • Novonix Limited (NVX)
    • Brokerage Firm: Chardan Capital Markets
    • Ratings Change: Buy
    • Price Target: $4

Wednesday, May 29th, 2024

UPGRADES

  • Bain Capital Specialty Finance (BCSF)
    • Brokerage Firm: Wells Fargo
    • Ratings Change: Equal Weight>>Overweight
    • Price Target: $16>>$17
  • Eldorado Gold (EGO)
    • Brokerage Firm: RBC Capital Mkts
    • Ratings Change: Sector Perform>>Outperform
    • Price Target: $14>>$20
  • FS KKR Capital (FSK)
    • Brokerage Firm: Wells Fargo
    • Ratings Change: Equal Weight>>Overweight
    • Price Target: $19>>$21
  • Liberty Energy (LBRT)
    • Brokerage Firm: Citigroup
    • Ratings Change: Neutral>>Buy
    • Price Target: $24>>$32
  • Melco Resorts & Entertainment (MLCO)
    • Brokerage Firm: BofA Securities
    • Ratings Change: Neutral>>Buy
    • Price Target: $7.5>>$10.4
  • Norwegian Cruise Line (NCLH)
    • Brokerage Firm: Truist
    • Ratings Change: Hold>>Buy
    • Price Target: $20>>$21
  • United Airlines (UAL)
    • Brokerage Firm: Jefferies
    • Ratings Change: Hold>>Buy
    • Price Target: $54>>$65
  • Berkshire Hathaway (BRK.B)
    • Brokerage Firm: Argus
    • Ratings Change: Hold>>Buy
    • Price Target: $450
  • Core Scientific (CORZ)
    • Brokerage Firm: BTIG Research
    • Ratings Change: Neutral>>Buy
  • Dick’s Sporting Goods (DKS)
    • Brokerage Firm: BofA Securities
    • Ratings Change: Neutral>>Buy
    • Price Target: $240
  • VIZIO (VZIO)
    • Brokerage Firm: Barrington Research
    • Ratings Change: Mkt Perform>>Outperform

DOWNGRADES

  • American Airlines (AAL)
    • Brokerage Firm: Jefferies
    • Ratings Change: Buy>>Hold
    • Price Target: $17>>$12
  • CubeSmart (CUBE)
    • Brokerage Firm: BMO Capital Markets
    • Ratings Change: Outperform>>Market Perform
    • Price Target: $50>>$47
  • First Solar (FSLR)
    • Brokerage Firm: DZ Bank
    • Ratings Change: Buy>>Hold
    • Price Target: $270
  • Goldman Sachs BDC (GSBD)
    • Brokerage Firm: Wells Fargo
    • Ratings Change: Equal Weight>>Underweight
    • Price Target: $15>>$14
  • Grainger (GWW)
    • Brokerage Firm: Robert W. Baird
    • Ratings Change: Outperform>>Neutral
    • Price Target: $1000>>$975
  • MSC Industrial (MSM)
    • Brokerage Firm: Robert W. Baird
    • Ratings Change: Outperform>>Neutral
    • Price Target: $112>>$95
  • Bank OZK (OZK)
    • Brokerage Firm: Citigroup
    • Ratings Change: Buy>>Sell
    • Price Target: $57>>$37
  • Triple Flag Precious Metals Corp. (TFPM)
    • Brokerage Firm: RBC Capital Mkts
    • Ratings Change: Outperform>>Sector Perform
    • Price Target: $15>>$19
  • TriplePoint Venture Growth (TPVG)
    • Brokerage Firm: Wells Fargo
    • Ratings Change: Equal Weight>>Underweight
    • Price Target: $9.5>>$8.5
  • Wesco (WCC)
    • Brokerage Firm: Robert W. Baird
    • Ratings Change: Outperform>>Neutral
    • Price Target: $200>>$195
  • Ikena Oncology (IKNA)
    • Brokerage Firm: Wedbush
    • Ratings Change: Outperform>>Neutral
    • Price Target: $8>>$2
  • Atlantica Sustainable Infrastructure plc (AY)
    • Brokerage Firm: Seaport Research Partners
    • Ratings Change: Buy>>Neutral
  • American Airlines (AAL)
    • Brokerage Firm: Seaport Research Partners
    • Ratings Change: Buy>>Neutral
  • Anglo American (NGLOY)
    • Brokerage Firm: Jefferies
    • Ratings Change: Buy>>Hold
  • Bank of Montreal (BMO)
    • Brokerage Firm: Desjardins
    • Ratings Change: Buy>>Hold

COVERAGE INITIATED

  • Fortrea (FTRE)
    • Brokerage Firm: TD Cowen
    • Ratings Change: Hold
    • Price Target: $27
  • Medpace (MEDP)
    • Brokerage Firm: TD Cowen
    • Ratings Change: Buy
    • Price Target: $452
  • MindMed (MNMD)
    • Brokerage Firm: Robert W. Baird
    • Ratings Change: Outperform
    • Price Target: $27
  • SAGE Therapeutics (SAGE)
    • Brokerage Firm: Citigroup
    • Ratings Change: Sell
    • Price Target: $8
  • SAGE Therapeutics (SAGE)
    • Brokerage Firm: Robert W. Baird
    • Ratings Change: Neutral
    • Price Target: $15
  • CareTrust REIT (CTRE)
    • Brokerage Firm: Wedbush
    • Ratings Change: Neutral
    • Price Target: $26
  • Palo Alto Networks (PANW)
    • Brokerage Firm: Daiwa Securities
    • Ratings Change: Outperform
    • Price Target: $350
  • SharkNinja (SN)
    • Brokerage Firm: China Renaissance
    • Ratings Change: Buy

Tuesday, May 28th, 2024

UPGRADES

  • Airbnb (ABNB)
    • Brokerage Firm: Wedbush
    • Ratings Change: Neutral >> Outperform
    • Price Target: $160 >> $165
  • Autoliv (ALV)
    • Brokerage Firm: UBS
    • Ratings Change: Neutral >> Buy
    • Price Target: $102 >> $141
  • CytomX Therapeutics (CTMX)
    • Brokerage Firm: Piper Sandler
    • Ratings Change: Neutral >> Overweight
    • Price Target: $2.25 >> $3.5
  • DuPont (DD)
    • Brokerage Firm: Citigroup
    • Ratings Change: Neutral >> Buy
    • Price Target: $85 >> $95
  • Deckers Outdoor (DECK)
    • Brokerage Firm: Truist
    • Ratings Change: Hold >> Buy
    • Price Target: $1011 >> $1200
  • Duolingo (DUOL)
    • Brokerage Firm: JMP Securities
    • Ratings Change: Mkt Perform >> Mkt Outperform
    • Price Target: $260
  • Futu Holdings (FUTU)
    • Brokerage Firm: JP Morgan
    • Ratings Change: Neutral >> Overweight
    • Price Target: $62 >> $92
  • Forward Air (FWRD)
    • Brokerage Firm: Wolfe Research
    • Ratings Change: Underperform >> Peer Perform
  • Globant (GLOB)
    • Brokerage Firm: UBS
    • Ratings Change: Neutral >> Buy
    • Price Target: $240 >> $230
  • Huntington Banc (HBAN)
    • Brokerage Firm: JP Morgan
    • Ratings Change: Neutral >> Overweight
    • Price Target: $16 >> $18
  • Norwegian Cruise Line (NCLH)
    • Brokerage Firm: Mizuho
    • Ratings Change: Neutral >> Buy
    • Price Target: $21 >> $24
  • On (ONON)
    • Brokerage Firm: Truist
    • Ratings Change: Hold >> Buy
    • Price Target: $34 >> $46
  • Parker-Hannifin (PH)
    • Brokerage Firm: Mizuho
    • Ratings Change: Neutral >> Buy
    • Price Target: $550 >> $650
  • Sunstone Hotel (SHO)
    • Brokerage Firm: Robert W. Baird
    • Ratings Change: Neutral >> Outperform
    • Price Target: $11 >> $12
  • Sysco (SYY)
    • Brokerage Firm: Guggenheim
    • Ratings Change: Neutral >> Buy
    • Price Target: $85
  • Central Garden (CENT)
    • Brokerage Firm: Argus
    • Ratings Change: Hold >> Buy
    • Price Target: $50
  • Expensify (EXFY)
    • Brokerage Firm: Morgan Stanley
    • Ratings Change: Underweight >> Equal-Weight

DOWNGRADES

  • Aegon N.V. (AEG)
    • Brokerage Firm: UBS
    • Ratings Change: Buy >> Neutral
  • AFC Gamma (AFCG)
    • Brokerage Firm: Compass Point
    • Ratings Change: Neutral >> Sell
    • Price Target: $10
  • Live Nation (LYV)
    • Brokerage Firm: Northcoast
    • Ratings Change: Buy >> Neutral
  • Sarepta Therapeutics (SRPT)
    • Brokerage Firm: RBC Capital Mkts
    • Ratings Change: Outperform >> Sector Perform
    • Price Target: $157 >> $142
  • Triumph Group (TGI)
    • Brokerage Firm: TD Cowen
    • Ratings Change: Buy >> Hold
    • Price Target: $19.5 >> $14
  • Zscaler (ZS)
    • Brokerage Firm: Rosenblatt
    • Ratings Change: Buy >> Neutral
    • Price Target: $190
    • Brokerage Firm: Wells Fargo
    • Ratings Change: Overweight >> Equal Weight
    • Price Target: $275 >> $182
  • Southwest Air (LUV)
    • Brokerage Firm: Argus
    • Ratings Change: Buy >> Hold

COVERAGE INITIATED

  • Civitas Resources (CIVI)
    • Brokerage Firm: RBC Capital Mkts
    • Ratings Change: Outperform
    • Price Target: $90
  • Fortrea (FTRE)
    • Brokerage Firm: Mizuho
    • Ratings Change: Neutral
    • Price Target: $27
  • iBio (IBIO)
    • Brokerage Firm: Chardan Capital Markets
    • Ratings Change: Buy
    • Price Target: $5
  • Kratos Defense and Security (KTOS)
    • Brokerage Firm: JMP Securities
    • Ratings Change: Mkt Outperform
    • Price Target: $27
  • Medpace (MEDP)
    • Brokerage Firm: Mizuho
    • Ratings Change: Buy
    • Price Target: $435
  • Napco Security Systems (NSSC)
    • Brokerage Firm: TD Cowen
    • Ratings Change: Buy
    • Price Target: $60
  • Millicom International Cellular (TIGO)
    • Brokerage Firm: JP Morgan
    • Ratings Change: Overweight
    • Price Target: $30
  • Viking Holdings Ltd (VIK)
    • Brokerage Firm: Wells Fargo
    • Ratings Change: Overweight
    • Price Target: $35
    • Brokerage Firm: JP Morgan
    • Ratings Change: Overweight
    • Price Target: $34
    • Brokerage Firm: UBS
    • Ratings Change: Buy
    • Price Target: $35
    • Brokerage Firm: Redburn Atlantic
    • Ratings Change: Neutral
    • Price Target: $29
    • Brokerage Firm: Stifel
    • Ratings Change: Buy
    • Price Target: $37
    • Brokerage Firm: Morgan Stanley
    • Ratings Change: Equal-Weight
    • Price Target: $31
    • Brokerage Firm: BofA Securities
    • Ratings Change: Buy
    • Price Target: $35
  • Ares Management (ARES)
    • Brokerage Firm: Deutsche Bank
    • Ratings Change: Buy
    • Price Target: $176